Regulation of HFE expression by poly(ADP-ribose) polymerase-1 (PARP1) through an inverted repeat DNA sequence in the distal promoter

被引:10
|
作者
Pelham, Christopher [1 ]
Jimenez, Tamara [1 ]
Rodova, Marianna [1 ]
Rudolph, Angela [1 ]
Chipps, Elizabeth [1 ]
Islam, M. Rafiq [1 ]
机构
[1] NW Missouri State Univ, Biochem Lab, Maryville, MO 64468 USA
关键词
HFE; PARP1; Negative element; Inverted repeat; Cruciform; HAMP; TRANSCRIPTIONAL REPRESSION; CRUCIFORM STRUCTURES; INDUCED APOPTOSIS; IRON-ABSORPTION; DOWN-REGULATION; BINDING; GENE; MODULATION; CLEAVAGE; HEMOCHROMATOSIS;
D O I
10.1016/j.bbagrm.2013.10.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hereditary hemochromatosis (HH) is a common autosomal recessive disorder of iron overload among Caucasians of northern European descent. Over 85% of all cases with HH are due to mutations in the hemochromatosis protein (HFE) involved in iron metabolism. Although the importance in iron homeostasis is well recognized, the mechanism of sensing and regulating iron absorption by HFE, especially in the absence of iron response element in its gene, is not fully understood. In this report, we have identified an inverted repeat sequence (ATGGTcttACCTA) within 1700 bp (-16751+35) of the HFE promoter capable to form cruciform structure that binds PARP1 and strongly represses HFE promoter. Knockdown of PARP1 increases HFE mRNA and protein. Similarly, hemin or FeCl3 treatments resulted in increase in HFE expression by reducing nuclear PARP1 pool via its apoptosis induced cleavage, leading to upregulation of the iron regulatory hormone hepcidin mRNA. Thus, PARP1 binding to the inverted repeat sequence on the HFE promoter may serve as a novel iron sensing mechanism as increased iron level can trigger PARP1 cleavage and relief of HFE transcriptional repression. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:1257 / 1265
页数:9
相关论文
共 50 条
  • [31] Natural Inhibitors of Poly(ADP-ribose) Polymerase-1
    Banasik, Marek
    Stedeford, Todd
    Strosznajder, Robert P.
    MOLECULAR NEUROBIOLOGY, 2012, 46 (01) : 55 - 63
  • [32] Poly(ADP-ribose) Polymerase-1 Expression in Alzheimer's Disease
    Zeng, Jianying
    Libien, Jenny
    Shaik, Fatima
    Krasnozhen, Olga
    Hernandez, A. Ivan
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2012, 71 (06): : 564 - 564
  • [33] Biological activity of poly(ADP-ribose)polymerase-1
    Kilianska, Zofia M.
    Zolnierczyk, Jolanta
    Wesierska-Gadek, Jozefa
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2010, 64 : 344 - 363
  • [34] Natural Inhibitors of Poly(ADP-ribose) Polymerase-1
    Marek Banasik
    Todd Stedeford
    Robert P. Strosznajder
    Molecular Neurobiology, 2012, 46 : 55 - 63
  • [35] Poly(ADP-ribose) Polymerase 1 (PARP1) Expression in iTreg Plays a Role in the Pathogenesis of Experimental Colitis
    Larmonier, Claire B.
    Shehab, Kareem W.
    McFadden, Rita-Marie T.
    Jamwal, Deepa R.
    Kiela, Pawel R.
    Ghishan, Fayez K.
    GASTROENTEROLOGY, 2015, 148 (04) : S326 - S326
  • [36] Poly (ADP-ribose) polymerase-1 (PARP1) inhibitor BSI-201 in combination with temozolomide (TMZ) in malignant glioma
    Blakeley, J. O.
    Ye, X.
    Grossman, S. A.
    Mikkelsen, T.
    Rosenfeld, M. R.
    Bradley, C. R.
    Eichler, A. F.
    Nabors, L. B.
    Desideri, S.
    Supko, J. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [37] Analysis of poly(ADP-ribose) polymerase-1 (PARP1) gene alteration in human germ cell tumor cell lines
    Ogino, Hideki
    Nakayama, Robert
    Sakamoto, Hiromi
    Yoshida, Teruhiko
    Sugimura, Takashi
    Masutani, Mitsuko
    CANCER GENETICS AND CYTOGENETICS, 2010, 197 (01) : 8 - 15
  • [38] Poly(ADP-ribose) polymerase-1 (PARP1) and p53 labelling index correlates with tumour grade in meningiomas
    Csonka, Tamas
    Murnyak, Balaks
    Szepesi, Rita
    Kurucz, Andrea
    Klekner, Almos
    Hortobagyi, Tibor
    FOLIA NEUROPATHOLOGICA, 2014, 52 (02) : 111 - 120
  • [39] Therapeutic Targeting of Poly(ADP-Ribose) Polymerase-1 (PARP1) in Cancer: Current Developments, Therapeutic Strategies, and Future Opportunities
    Rajawat, Jyotika
    Shukla, Nidhi
    Mishra, Durga Prasad
    MEDICINAL RESEARCH REVIEWS, 2017, 37 (06) : 1461 - 1491
  • [40] Targeting BRCA1 Localization to Augment Tumor Cell Susceptibility to Poly (ADP-ribose) Polymerase-1 (PARP1) Inhibition
    Yang, S.
    Nowsheen, S.
    Xia, F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S89 - S89